UMRX

Unum Therapeutics Inc.CIK 1622229 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for UMRX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for UMRX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Ros Matthew	Director	7	$0	$0	2020-10-01
Ferrante Karen Jean	Director	12	$0	$0	2020-10-01
CAIN CHRISTOPHER W.	Director	1	$0	$0	2020-08-27
Harwin Peter Evan	Director	1	$0	$0	2020-08-27
Venrock Healthcare Capital Partners III, L.P.	10% Owner	3	$1.14M	$0	2020-08-18
Fairmount Funds Management LLC	10% Owner	6	$20.00M	$0	2020-07-09
Green John L.	See Remarks	8	$0	$0	2020-07-06
Aldag Jorn	Director	11	$0	$0	2020-07-01
Booth Bruce	Director	16	$1.13M	$0	2020-07-01
Morris Arlene	Director	2	$0	$0	2020-06-09
Sachs Jessica	Chief Medical Officer	2	$0	$0	2020-02-11
Osborne Matthew Scott	Chief Financial Officer	2	$0	$0	2020-02-11
HODGE GEOFFREY	Chief Technical Officer	2	$0	$0	2020-02-11
Ettenberg Seth	Chief Scientific Officer	22	$0	$463.4K	2020-02-11
Ratcliffe Liam	Director	11	$6.60M	$0	2019-06-14
PEREZ ROBERT J	Director	5	$0	$0	2019-06-14
WILSON CHARLES	Chief Executive Officer	1	$0	$0	2019-03-01
VASCONCELLES MICHAEL	Chief Medical Officer	1	$0	$0	2019-03-01
FIL Ltd	Other	4	$0	$0	2018-04-03
FMR LLC	Other	13	$1.13M	$0	2018-04-03
Atlas Venture Associates IX, LLC	10% Owner	5	$1.13M	$0	2018-04-03

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Ros Matthew	Director	A Award deriv	2020-10-01	2020-10-02	9,247	$1.35	$12.5K	9,247	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2020-10-01	2020-10-02	8,878	$1.35	$12.0K	8,878	SEC↗
CAIN CHRISTOPHER W.	Director	A Award deriv	2020-08-27	2020-08-31	28,661	—	$0	28,661	SEC↗
Harwin Peter Evan	Director	A Award deriv	2020-08-27	2020-08-31	28,661	—	$0	28,661	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2020-08-18	2020-08-18	101,000	$2.62	$264.6K	4,355,273	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2020-08-17	2020-08-18	250,000	$2.57	$642.5K	4,254,273	SEC↗
Venrock Healthcare Capital Par	10% Owner	P Buy	2020-08-14	2020-08-18	100,000	$2.30	$230.0K	4,004,273	SEC↗
Fairmount Funds Management LLC	10% Owner	P Buy deriv	2020-07-09	2020-07-13	3,692	$880.00	$3.25M	11,914	SEC↗
Fairmount Funds Management LLC	10% Owner	P Buy deriv	2020-07-09	2020-07-13	19,035	$880.00	$16.75M	55,500	SEC↗
Fairmount Funds Management LLC	10% Owner	J Other deriv	2020-07-06	2020-07-08	36,465	—	$0	36,465	SEC↗
Fairmount Funds Management LLC	10% Owner	J Other deriv	2020-07-06	2020-07-08	8,222	—	$0	8,222	SEC↗
Green John L.	Chief Financial Officer	M Exercise deriv	2020-07-06	2020-07-08	109,459	—	$0	0	SEC↗
Fairmount Funds Management LLC	10% Owner	J Other	2020-07-06	2020-07-08	1,147,406	—	$0	1,147,406	SEC↗
Fairmount Funds Management LLC	10% Owner	J Other	2020-07-06	2020-07-08	5,088,497	—	$0	5,088,497	SEC↗
Green John L.	Chief Financial Officer	F Tax w/h	2020-07-06	2020-07-08	31,873	$2.20	$70.1K	77,586	SEC↗
Green John L.	Chief Financial Officer	M Exercise	2020-07-06	2020-07-08	109,459	—	$0	109,459	SEC↗
Aldag Jorn	Director	A Award deriv	2020-07-01	2020-07-06	40,090	$0.31	$12.4K	40,090	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2020-07-01	2020-07-06	38,487	$0.31	$11.9K	38,487	SEC↗
Ros Matthew	Director	A Award deriv	2020-07-01	2020-07-06	35,280	$0.31	$10.9K	35,280	SEC↗
Booth Bruce	Director	A Award deriv	2020-07-01	2020-07-06	61,338	$0.31	$19.0K	61,338	SEC↗
Aldag Jorn	Director	A Award deriv	2020-06-09	2020-06-11	14,331	—	$0	14,331	SEC↗
Booth Bruce	Director	A Award deriv	2020-06-09	2020-06-11	14,331	—	$0	14,331	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2020-06-09	2020-06-11	14,331	—	$0	14,331	SEC↗
Morris Arlene	Director	A Award deriv	2020-06-09	2020-06-11	14,331	—	$0	14,331	SEC↗
Ros Matthew	Director	A Award deriv	2020-06-09	2020-06-11	14,331	—	$0	14,331	SEC↗
Aldag Jorn	Director	A Award deriv	2020-04-06	2020-04-08	56,690	$0.22	$12.5K	56,690	SEC↗
Booth Bruce	Director	A Award deriv	2020-04-06	2020-04-08	86,735	$0.22	$19.1K	86,735	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2020-04-06	2020-04-08	54,422	$0.22	$12.0K	54,422	SEC↗
Ros Matthew	Director	A Award deriv	2020-04-06	2020-04-08	49,887	$0.22	$11.0K	49,887	SEC↗
Ettenberg Seth	Chief Scientific Officer	A Award deriv	2020-02-11	2020-02-13	153,600	—	$0	153,600	SEC↗
Green John L.	See Remarks	A Award deriv	2020-02-11	2020-02-13	64,400	—	$0	64,400	SEC↗
HODGE GEOFFREY	Chief Technical Officer	A Award deriv	2020-02-11	2020-02-13	112,400	—	$0	112,400	SEC↗
Osborne Matthew Scott	Chief Financial Officer	A Award deriv	2020-02-11	2020-02-13	160,400	—	$0	160,400	SEC↗
Sachs Jessica	Chief Medical Officer	A Award deriv	2020-02-11	2020-02-13	133,200	—	$0	133,200	SEC↗
Ros Matthew	Director	A Award deriv	2020-01-02	2020-01-06	24,274	$0.45	$10.9K	24,274	SEC↗
Booth Bruce	Director	A Award deriv	2020-01-02	2020-01-06	39,996	$0.45	$18.0K	39,996	SEC↗
Aldag Jorn	Director	A Award deriv	2020-01-02	2020-01-06	29,790	$0.45	$13.4K	29,790	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2020-01-02	2020-01-06	26,480	$0.45	$11.9K	26,480	SEC↗
Green John L.	See Remarks	A Award deriv	2019-11-19	2019-11-21	109,459	—	$0	109,459	SEC↗
Ettenberg Seth	Chief Scientific Officer	A Award deriv	2019-11-19	2019-11-21	280,000	—	$0	280,000	SEC↗
Aldag Jorn	Director	A Award deriv	2019-10-01	2019-10-03	15,352	$0.88	$13.5K	15,352	SEC↗
Booth Bruce	Director	A Award deriv	2019-10-01	2019-10-03	20,611	$0.88	$18.1K	20,611	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2019-10-01	2019-10-03	13,646	$0.88	$12.0K	13,646	SEC↗
Ros Matthew	Director	A Award deriv	2019-10-01	2019-10-03	12,509	$0.88	$11.0K	12,509	SEC↗
Morris Arlene	Director	A Award deriv	2019-07-26	2019-07-29	28,661	—	$0	28,661	SEC↗
Ros Matthew	Director	A Award deriv	2019-07-26	2019-07-29	28,661	—	$0	28,661	SEC↗
Sachs Jessica	Chief Medical Officer	A Award deriv	2019-07-19	2019-07-22	123,800	—	$0	123,800	SEC↗
Aldag Jorn	Director	A Award deriv	2019-07-01	2019-07-03	7,608	$1.77	$13.5K	7,608	SEC↗
Booth Bruce	Director	A Award deriv	2019-07-01	2019-07-03	10,285	$1.77	$18.2K	10,285	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2019-07-01	2019-07-03	6,199	$1.77	$11.0K	6,199	SEC↗
Osborne Matthew Scott	Chief Financial Officer	A Award deriv	2019-06-24	2019-06-25	190,000	—	$0	190,000	SEC↗
Aldag Jorn	Director	A Award deriv	2019-06-18	2019-06-20	14,331	—	$0	14,331	SEC↗
Booth Bruce	Director	A Award deriv	2019-06-18	2019-06-20	14,331	—	$0	14,331	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2019-06-18	2019-06-20	14,331	—	$0	14,331	SEC↗
PEREZ ROBERT J	Director	A Award deriv	2019-06-14	2019-06-18	7,131	$1.67	$11.9K	7,131	SEC↗
Ratcliffe Liam	Director	A Award deriv	2019-06-14	2019-06-18	7,881	$1.67	$13.2K	7,881	SEC↗
Green John L.	See Remarks	A Award deriv	2019-04-24	2019-04-26	16,814	—	$0	16,814	SEC↗
Green John L.	See Remarks	A Award deriv	2019-04-19	2019-04-23	21,017	—	$0	21,017	SEC↗
Aldag Jorn	Director	A Award deriv	2019-04-01	2019-04-03	4,966	$2.72	$13.5K	4,966	SEC↗
Booth Bruce	Director	A Award deriv	2019-04-01	2019-04-03	6,714	$2.72	$18.3K	6,714	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2019-04-01	2019-04-03	4,047	$2.72	$11.0K	4,047	SEC↗
PEREZ ROBERT J	Director	A Award deriv	2019-04-01	2019-04-03	4,369	$2.72	$11.9K	4,369	SEC↗
Ratcliffe Liam	Director	A Award deriv	2019-04-01	2019-04-03	4,829	$2.72	$13.1K	4,829	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise deriv	2019-03-25	2019-04-03	11,485	—	$0	329,145	SEC↗
Ettenberg Seth	Chief Scientific Officer	A Award deriv	2019-03-25	2019-03-26	11,485	—	$0	329,145	SEC↗
Ettenberg Seth	Chief Scientific Officer	S Sale	2019-03-25	2019-03-26	11,485	$4.12	$47.3K	0	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise	2019-03-25	2019-03-26	11,485	$0.18	$2.1K	11,485	SEC↗
Ettenberg Seth	Chief Scientific Officer	A Award deriv	2019-03-01	2019-04-11	69,700	—	$0	69,700	SEC↗
Green John L.	See Remarks	A Award deriv	2019-03-01	2019-04-11	21,017	—	$0	21,017	SEC↗
HODGE GEOFFREY	Chief Technical Officer	A Award deriv	2019-03-01	2019-04-11	28,000	—	$0	28,000	SEC↗
VASCONCELLES MICHAEL	Chief Medical Officer	A Award deriv	2019-03-01	2019-04-11	61,900	—	$0	61,900	SEC↗
WILSON CHARLES	Chief Executive Officer	A Award deriv	2019-03-01	2019-04-11	174,400	—	$0	174,400	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise deriv	2019-02-25	2019-02-26	11,485	—	$0	340,630	SEC↗
Ettenberg Seth	Chief Scientific Officer	S Sale	2019-02-25	2019-02-26	11,485	$4.25	$48.8K	0	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise	2019-02-25	2019-02-26	11,485	$0.18	$2.1K	11,485	SEC↗
Aldag Jorn	Director	A Award deriv	2019-01-02	2019-01-04	4,999	$2.70	$13.5K	4,999	SEC↗
Booth Bruce	Director	A Award deriv	2019-01-02	2019-01-04	6,757	$2.70	$18.2K	6,757	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2019-01-02	2019-01-04	4,073	$2.70	$11.0K	4,073	SEC↗
PEREZ ROBERT J	Director	A Award deriv	2019-01-02	2019-01-04	4,397	$2.70	$11.9K	4,397	SEC↗
Ratcliffe Liam	Director	A Award deriv	2019-01-02	2019-01-04	4,860	$2.70	$13.1K	4,860	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise deriv	2018-12-26	2018-12-28	11,485	—	$0	352,115	SEC↗
Ettenberg Seth	Chief Scientific Officer	S Sale	2018-12-26	2018-12-28	11,485	$4.05	$46.5K	0	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise	2018-12-26	2018-12-28	11,485	$0.18	$2.1K	11,485	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise deriv	2018-11-26	2018-11-26	11,485	—	$0	363,600	SEC↗
Ettenberg Seth	Chief Scientific Officer	S Sale	2018-11-26	2018-11-26	11,485	$7.00	$80.4K	0	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise	2018-11-26	2018-11-26	11,485	$0.18	$2.1K	11,485	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise deriv	2018-10-25	2018-10-29	11,485	—	$0	375,085	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise	2018-10-25	2018-10-29	11,485	$0.18	$2.1K	11,485	SEC↗
Ettenberg Seth	Chief Scientific Officer	S Sale	2018-10-25	2018-10-29	11,485	$8.46	$97.2K	0	SEC↗
Aldag Jorn	Director	A Award deriv	2018-10-01	2018-10-03	2,171	$6.22	$13.5K	2,171	SEC↗
Booth Bruce	Director	A Award deriv	2018-10-01	2018-10-03	2,935	$6.22	$18.3K	2,935	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2018-10-01	2018-10-03	1,769	$6.22	$11.0K	1,769	SEC↗
PEREZ ROBERT J	Director	A Award deriv	2018-10-01	2018-10-03	1,910	$6.22	$11.9K	1,910	SEC↗
Ratcliffe Liam	Director	A Award deriv	2018-10-01	2018-10-03	2,111	$6.22	$13.1K	2,111	SEC↗
Ettenberg Seth	Chief Scientific Officer	S Sale	2018-09-25	2018-09-26	11,485	$12.47	$143.2K	0	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise	2018-09-25	2018-09-26	11,485	$0.18	$2.1K	11,485	SEC↗
Ettenberg Seth	Chief Scientific Officer	M Exercise deriv	2018-09-24	2018-09-26	11,485	—	$0	386,570	SEC↗
Aldag Jorn	Director	A Award deriv	2018-07-26	2018-09-26	1,547	$8.72	$13.5K	1,547	SEC↗
Booth Bruce	Director	A Award deriv	2018-07-26	2018-09-26	2,092	$8.72	$18.2K	2,092	SEC↗
Ferrante Karen Jean	Director	A Award deriv	2018-07-26	2018-09-26	1,261	$8.72	$11.0K	1,261	SEC↗
PEREZ ROBERT J	Director	A Award deriv	2018-07-26	2018-09-26	1,361	$8.72	$11.9K	1,361	SEC↗
Ratcliffe Liam	Director	A Award deriv	2018-07-26	2018-09-26	1,504	$8.72	$13.1K	1,504	SEC↗
Ratcliffe Liam	Director	C Conversion deriv	2018-04-03	2018-04-03	977,835	—	$0	0	SEC↗
Ratcliffe Liam	Director	C Conversion deriv	2018-04-03	2018-04-03	977,836	—	$0	0	SEC↗
Booth Bruce	Director	C Conversion deriv	2018-04-03	2018-04-03	83,037	—	$0	0	SEC↗
Booth Bruce	Director	C Conversion deriv	2018-04-03	2018-04-03	3,184,446	—	$0	0	SEC↗
Atlas Venture Associates IX, L	10% Owner	C Conversion deriv	2018-04-03	2018-04-03	83,037	—	$0	0	SEC↗
Atlas Venture Associates IX, L	10% Owner	C Conversion deriv	2018-04-03	2018-04-03	3,184,446	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2018-04-03	2018-04-05	548,702	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2018-04-03	2018-04-05	35,614	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2018-04-03	2018-04-05	2,968,650	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2018-04-03	2018-04-05	13,505	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2018-04-03	2018-04-05	877	—	$0	0	SEC↗
FMR LLC	Other	C Conversion deriv	2018-04-03	2018-04-05	73,065	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2018-04-03	2018-04-05	42,931	—	$0	0	SEC↗
FIL Ltd	Other	C Conversion deriv	2018-04-03	2018-04-05	1,744,310	—	$0	0	SEC↗
Ratcliffe Liam	Director	C Conversion	2018-04-03	2018-04-03	622,772	—	$0	622,772	SEC↗
Ratcliffe Liam	Director	C Conversion	2018-04-03	2018-04-03	622,773	—	$0	622,773	SEC↗
Ratcliffe Liam	Director	P Buy	2018-04-03	2018-04-03	275,000	$12.00	$3.30M	897,772	SEC↗
Ratcliffe Liam	Director	P Buy	2018-04-03	2018-04-03	275,000	$12.00	$3.30M	897,773	SEC↗
Booth Bruce	Director	C Conversion	2018-04-03	2018-04-03	3,184,446	—	$0	3,184,446	SEC↗
Booth Bruce	Director	C Conversion	2018-04-03	2018-04-03	83,037	—	$0	3,267,483	SEC↗
Booth Bruce	Director	P Buy	2018-04-03	2018-04-03	94,052	$12.00	$1.13M	3,361,535	SEC↗
Atlas Venture Associates IX, L	10% Owner	P Buy	2018-04-03	2018-04-03	94,052	$12.00	$1.13M	3,361,535	SEC↗
Atlas Venture Associates IX, L	10% Owner	C Conversion	2018-04-03	2018-04-03	83,037	—	$0	3,267,483	SEC↗
Atlas Venture Associates IX, L	10% Owner	C Conversion	2018-04-03	2018-04-03	3,184,446	—	$0	3,184,446	SEC↗
FMR LLC	Other	C Conversion	2018-04-03	2018-04-05	8,601	—	$0	358,063	SEC↗
FMR LLC	Other	P Buy	2018-04-03	2018-04-05	94,052	$12.00	$1.13M	452,115	SEC↗
FMR LLC	Other	C Conversion	2018-04-03	2018-04-05	1,890,701	—	$0	1,890,701	SEC↗
FMR LLC	Other	C Conversion	2018-04-03	2018-04-05	46,534	—	$0	1,937,235	SEC↗
FMR LLC	Other	C Conversion	2018-04-03	2018-04-05	22,682	—	$0	22,682	SEC↗
FMR LLC	Other	C Conversion	2018-04-03	2018-04-05	558	—	$0	23,240	SEC↗
FMR LLC	Other	C Conversion	2018-04-03	2018-04-05	349,462	—	$0	349,462	SEC↗
FIL Ltd	Other	C Conversion	2018-04-03	2018-04-05	27,342	—	$0	1,138,274	SEC↗
FIL Ltd	Other	C Conversion	2018-04-03	2018-04-05	1,110,932	—	$0	1,110,932	SEC↗